Rocket Pharmaceuticals’ Post

🚀 Vertex Pharmaceuticals (VRTX) is Trending! 🌟 Vertex Pharmaceuticals (VRTX) is making waves in the biotech sector, capturing the attention of investors and industry experts alike. 🌐 🔍 Key Highlights: -Strong Market Performance: Vertex continues to show robust market trends, driven by its innovative approach and strategic focus on transformative medicines. -Innovative Pipeline: The company’s dedication to developing cutting-edge treatments for serious diseases keeps it at the forefront of biotech innovation. -Financial Strength: Vertex's solid financial health and consistent revenue growth reflect its effective business strategies and market adaptability. -Vertex's commitment to advancing healthcare through groundbreaking research and development is truly inspiring. Their focus on delivering high-impact therapies underscores their leadership in the biotech industry. 🌟 Let's celebrate Vertex's achievements and anticipate more groundbreaking developments ahead! #VertexPharmaceuticals #VRTX #BiotechInnovation #HealthcareLeadership #MarketTrends #InvestmentNews #CuttingEdgeResearch #TransformativeMedicines #FinancialGrowth #InvestorUpdate

New: Former Novartis CEO Joe Jimenez and the pharma's long-time research leader Mark Fishman are targeting $400 million for their third fund at Aditum Bio. The Oakland, CA-based firm in-licenses drugs, sets up a company around them and takes the experimental medicines through clinical development toward an M&A exit, like it has done with Versanis Bio, bought by Eli Lilly for up to $1.9 billion last year. Aditum has created 10 companies so far. “I was very clear with all of my investors that out of the 10 companies, I expect only three of them to provide good data, and seven of them will shut down,” Jimenez said in an interview with Endpoints News last fall. “Many times in pharma, if you’re in Phase 2 and you don’t get a positive readout, there’s a project team that’s willing to convince management that all they have to do is change the patient population, and they’re going to have success. That’s not what we’re about.” #biotech #vc #lifesciences #venturecapital #drugdevelopment

Thoughts on this? >> After 14 years calling partnering shots at Genentech/Roche, James Sabry is headed back into the biotech fray >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #healthcare #pharmaceutical #pharma #biotech

This is really interesting! Nimbus Therapeutics has made waves with this setup, which started with Bruce Booth from Atlas Venture. It’s impressive how this model has led to deals worth over $7.1B, returned $4.1B to investors, and pushed three programs into clinical trials. It shows that while the business model is important, solid science and data are key. #biotech, #pharma, #businessmodel

Thoughts on this? >> After 14 years calling partnering shots at Genentech/Roche, James Sabry is headed back into the biotech fray >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #pharma #biotech #healthcare

Thoughts on this? >> In pivot to buzzy ADCs, London biotech Myricx raises $114M with Lilly's support >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #biotech #pharma #productmarketing

Thoughts on this? >> In pivot to buzzy ADCs, London biotech Myricx raises $114M with Lilly's support >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #productmarketing #biotech #pharmaceutical

Thoughts on this? >> Acquired biotech accuses Novartis of letting IL-15 asset 'wither on the vine' >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #productmarketing #healthcare #pharma

Thoughts on this? >> Insilico Medicine, an early force in AI-driven drug R&D, lets IPO plans peter out for second year in a row >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #healthcare #biotech #pharmaceutical

We are proud to share that we have helped a top 10 CMO secure 25 new business meetings with pharma and biotech leaders while travelling this week. Since 2013, we have helped our clients connect with the right decision-makers in the #pharma, #biotech, and #medtech industries. We look forward to continuing our mission of connecting people intelligently in the pharma and biotech service providers. 👉 𝗜𝗳 𝘆𝗼𝘂'𝗱 𝗹𝗶𝗸𝗲 𝘁𝗼 𝗸𝗻𝗼𝘄 𝗺𝗼𝗿𝗲 𝘀𝗲𝗻𝗱 𝘂𝘀 𝗮 𝗺𝗲𝘀𝘀𝗮𝗴𝗲 𝗼𝗻 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻. 👏Celebrating 10 years of connecting people in the pharma and biotech industry! #PharmaTargeting - The home of Pharma Service Providers. #pharmaserviceproviders Anil Kumar